References
- Armitage JO. (2000) Myelodysplasia and acute leukemia after autologous bone marrow transplantation. J Clin Oncol, 18, 945-6. https://doi.org/10.1200/JCO.2000.18.5.945
- Bassal M, Mertens AC, Taylor L, et al (2006). Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol, 24, 476-83. https://doi.org/10.1200/JCO.2005.02.7235
- Brennan P, Scelo G, Hemminki K, et al (2005). Second primary cancers among 109.000 cases of non-Hodgkin's lymphoma. Br J Cancer, 93, 159. https://doi.org/10.1038/sj.bjc.6602654
- Chaturvedi AK, Engels EA, Gilbert ES, et al (2007). Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst, 99, 1634-43. https://doi.org/10.1093/jnci/djm201
- Cardous Ubbink MC, Heinen RC, Bakker PJ, et al (2007). Risk of second malignancies in long-term survivors of childhood cancer. Eur J Cancer, 43, 351-62. https://doi.org/10.1016/j.ejca.2006.10.004
- Demirci U, Bugdayci F, Cakir A, et al (2010). Bilateral breast cancer in a survivor of acute lymphoblastic leukemia: a case report. Med Oncol, 27, 481-3. https://doi.org/10.1007/s12032-009-9238-4
- De Vathaire F, Hawkins M, Campbell S, et al (1999). Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment. Br J Cancer, 79, 1884-93. https://doi.org/10.1038/sj.bjc.6690300
- Dong C, Hemminki K (2001). Second primary neoplasms among 53159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: a search for common mechanisms. Br J Cancer, 85, 997-1005. https://doi.org/10.1054/bjoc.2001.1998
- Dores GM, Metayer C, Curtis RE, et al (2002). Second malignant neoplasms among long-term survivors of Hodgkin's disease: A population-based evaluation over 25 years. J Clin Oncol, 20, 3484-94. https://doi.org/10.1200/JCO.2002.09.038
- Dores GM, Cote TR, Travis LB (2006). New malignancies following Hodgkin lymphoma, non-Hodgkin lymphoma and myeloma. In: Curtis R, Freedman D, Ron F et al., eds. New malignancies among cancer survivors: SEER cancer registries, 1973-2000 (NIH Publ. No: 05-5302). 397, National Institutes of Health, Bethesda MD.
- Hisada M, Chen BE, Jaffe ES, Travis LB (2007). Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study. J Natl Cancer Inst, 99, 215-22. https://doi.org/10.1093/jnci/djk030
- Hodgson DC, Gilbert ES, Dores GM, et al (2007). Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma. J Clin Oncol, 25, 1489-97. https://doi.org/10.1200/JCO.2006.09.0936
- Ganz PA (2001). Late effects of cancer and its treatment. Semin Oncol Nurs, 17, 241-8. https://doi.org/10.1053/sonu.2001.27914
- Jenkinson HC, Hawkins MM, Stiller CA, et al (2004). Longterm population-based risks of second malignant neoplasms after childhood cancer in Britain. Br J Cancer, 91, 1905-10. https://doi.org/10.1038/sj.bjc.6602226
- Krishnan B, Morgan GJ (2007). Non-Hodgkin lymphoma secondary to cancer chemotherapy. Cancer Epidemiol Biomarkers Prev, 16, 377-80. https://doi.org/10.1158/1055-9965.EPI-06-1069
- Meadows AT, Friedman DL, Neglia JP, et al (2009). Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol, 27, 2356-62. https://doi.org/10.1200/JCO.2008.21.1920
- Neglia JP, Maedows AT, Robison LL, et al (1991). Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med, 325, 1330-6. https://doi.org/10.1056/NEJM199111073251902
- Neglia JP, Friedman DL, Yasui Y, et al (2001). Second malignant neoplasms in five-year survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst, 93, 618-29. https://doi.org/10.1093/jnci/93.8.618
- Ng AK, Travis LB (2008) Subsequent malignant neoplasms in cancer survivors. Cancer J, 14, 429-34. https://doi.org/10.1097/PPO.0b013e31818d8779
- Olsen JH, Garwicz S, Hertz H, et al (1993). Second malignant neoplasms after cancer in childhood or adolescence. Nordic Society of Paediatric Haematology and Oncology Association of the Nordic Cancer Registries. BMJ, 307, 1030-6. https://doi.org/10.1136/bmj.307.6911.1030
- Ries L, Eisner M, Kosary C, et al (2006). SEER cancer statistics review. 1975-2003. National Cancer Institute, Bethesda MD.
- Swerdlow SH, Campo E, Harris NL, et al (2008). In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th ed, 12-13, Lyon, IARC Pres.
- Travis LB, Curtis RE, Glimelius B, et al (1993). Second cancers among long-term survivors of non-Hodgkin's disease. J Natl Cancer Inst, 85, 1932-7. https://doi.org/10.1093/jnci/85.23.1932
- Travis LB, Curtis Re, Glimelius B, et al (1995). Bladder and kidney cancer following cyclophosphomide therapy for non-Hodgkin's lymphoma. J Natl Cancer Inst, 87, 524. https://doi.org/10.1093/jnci/87.7.524
- Tward JD, Wendland MM, Shrieve DC, Szabo A, Gaffney DK (2006). The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma. Cancer, 107, 108-15. https://doi.org/10.1002/cncr.21971
Cited by
- Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in the Diagnosis of Lymphoma vol.15, pp.10, 2014, https://doi.org/10.7314/APJCP.2014.15.10.4169
- Type Distribution of Lymphomas in Lebanon: Five-Year Single Institution Experience vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5825
- Lung cancer and concurrent or sequential lymphoma: Two case reports with hypersensitivity to bevacizumab and a review of the literature pp.1792-1082, 2014, https://doi.org/10.3892/ol.2014.2717
- Prognostic impact of a past or synchronous second cancer in diffuse large B cell lymphoma vol.8, pp.1, 2018, https://doi.org/10.1038/s41408-017-0043-6
- One Pulmonary Lesion, 2 Synchronous Malignancies vol.6, pp.2324-7096, 2018, https://doi.org/10.1177/2324709618785934